Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes

• Published in: EBioMedicine 2020-04, Vol.54, p.102732-102732, Article 102732
• Main Authors: Campuzano, Oscar, Sarquella-Brugada, Georgia, Fernandez-Falgueras, Anna, Coll, Mónica, Iglesias, Anna, Ferrer-Costa, Carles, Cesar, Sergi, Arbelo, Elena, García-Álvarez, Ana, Jordà, Paloma, Toro, Rocío, Tiron de Llano, Coloma, Grassi, Simone, Oliva, Antonio, Brugada, Josep, Brugada, Ramon
• Format: Article
• Language: English
• Subjects: Adult; Arrhythmias; Arrhythmias, Cardiac - epidemiology; Arrhythmias, Cardiac - genetics; Female; Genetics; Humans; Male; Middle Aged; Mutation; Pathogenicity; Research paper; Sudden cardiac death
• ISSN: 2352-3964; 2352-3964
• DOI: 10.1016/j.ebiom.2020.102732

Accurate interpretation of rare genetic variants is a challenge for clinical translation. Updates in recommendations for rare variant classification require the reanalysis and reclassification. We aim to perform an exhaustive re-analysis of rare variants associated with inherited arrhythmogenic syndromes, which were classified ten years ago, to determine whether their classification aligns with current standards and research findings. In 2010, the rare variants identified through genetic analysis were classified following recommendations available at that time. Nowadays, the same variants have been reclassified following current American College of Medical Genetics and Genomics recommendations. Our cohort included 104 cases diagnosed with inherited arrhythmogenic syndromes and 17 post-mortem cases in which inherited arrhythmogenic syndromes was cause of death. 71.87% of variants change their classification. While 65.62% of variants were classified as likely pathogenic in 2010, after reanalysis, only 17.96% remain as likely pathogenic. In 2010, 18.75% of variants were classified as uncertain role but nowadays 60.15% of variants are classified of unknown significance. Reclassification occurred in more than 70% of rare variants associated with inherited arrhythmogenic syndromes. Our results support the periodical reclassification and personalized clinical translation of rare variants to improve diagnosis and adjust treatment. Obra Social "La Caixa Foundation" (ID 100010434, LCF/PR/GN16/50290001 and LCF/PR/GN19/50320002), Fondo Investigacion Sanitaria (FIS PI16/01203 and FIS, PI17/01690), Sociedad Española de Cardiología, and “Fundacio Privada Daniel Bravo Andreu”.